Identification of subgroups of patients with type 2 diabetes with differences in renal function preservation, comparing patients receiving sodium‐glucose co‐transporter‐2 inhibitors with those receiving dipeptidyl peptidase‐4 inhibitors, using a supervised machine‐learning algorithm (PROFILE study): A retrospective analysis of a Japanese commercial medical database-Reference-Cited by-同舟云学术

Identification of subgroups of patients with type 2 diabetes with differences in renal function preservation, comparing patients receiving sodium‐glucose co‐transporter‐2 inhibitors with those receiving dipeptidyl peptidase‐4 inhibitors, using a supervised machine‐learning algorithm (PROFILE study): A retrospective analysis of a Japanese commercial medical database

Published:2019-08 Issue:8 Volume:21 Page:1925-1934
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Zhou Fang L.¹^ORCID,Watada Hirotaka²^ORCID,Tajima Yuki³^ORCID,Berthelot Mathilde⁴,Kang Dian⁴,Esnault Cyril⁴,Shuto Yujin³,Maegawa Hiroshi⁵,Koya Daisuke⁶

Affiliation:

1. Real World Evidence Generation, Sanofi Bridgewater New Jersey

2. Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine Tokyo Japan

3. Medical Affairs, Sanofi K.K. Tokyo Japan

4. Data Science Consulting, Quinten Paris France

5. Department of Medicine, Shiga University of Medical Science Otsu Japan

6. Department of Diabetology and Endocrinology, Kanazawa Medical University Uchinada Japan

Funder

Sanofi

Publisher

Wiley

Subject